RMD

Michael J. Rider

Known title: Global General CounselCIK: 0001982205

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

ResMed Q4 2026 Earnings Call Transcript Released. ResMed has released the transcript for its Q4 2026 earnings call, providing investors with detailed insights into the company's recent performance. This follows a quarterly earnings preview and places the stock within a broader market forecast for the mHealth sector. The release offers a factual record of management's comments on financial results and strategic direction.

this person other insiders at RMD

Transaction History

RMD▲ Buy$0
RMD▼ Sell$51K
RMD▼ Sell$13K
RMD▼ Sell$12K
RMD▼ Sell$12K
RMD▼ Sell$125K
RMD▼ Sell$43K
RMD▼ Sell$34K
RMD▼ Sell$179K
RMD▼ Sell$27K
RMD▲ Buy$0
RMD▼ Sell$14K
RMD▼ Sell$17K
RMD▼ Sell$10K
RMD▼ Sell$65K
RMD▼ Sell$14K
RMD▼ Sell$15K
RMD▼ Sell$16K
RMD▼ Sell$17K
RMD▼ Sell$18K
RMD▼ Sell$0
RMD▼ Sell$35K
RMD▼ Sell$43K
RMD▼ Sell$173K
RMD▼ Sell$34K
RMD▼ Sell$17K
RMD▼ Sell$204K
RMD▲ Buy$0
RMD▲ Buy$0
RMD▼ Sell$55K
RMD▼ Sell$15K
RMD▼ Sell$35K
RMD▼ Sell$0
RMD▼ Sell$17K
RMD▼ Sell$13K
RMD▼ Sell$20K
RMD▼ Sell$13K
RMD▼ Sell$4K
RMD▼ Sell$4K
RMD▼ Sell$4K
RMD▲ Buy$0
RMD▼ Sell$6K
RMD▼ Sell$5K

We use analytics to understand how market-wall is used. No personal data is sold.